Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

6.62USD
18 Jan 2019
Change (% chg)

$-0.07 (-1.05%)
Prev Close
$6.69
Open
$6.68
Day's High
$6.69
Day's Low
$6.43
Volume
38,052
Avg. Vol
19,153
52-wk High
$23.60
52-wk Low
$3.60

Latest Key Developments (Source: Significant Developments)

Catabasis Pharmaceuticals reports third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc :Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress.Q3 loss per share $0.31.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.Catabasis Pharmaceuticals Inc - co's current operating plan provides for cash to fund operations through august 2018​.  Full Article